3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colitis, Ulcerative
4
Inflammatory Bowel Diseases
3
Crohn Disease
3
Arthritis, Rheumatoid
3
Graft vs Host Disease
2
Cachexia
2
Anorexia
2
Recurrence
1
Rare Diseases
1
Psoriasis
1
Pancreatic Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Kidney Transplantation
1
Inflammation
1
Hypertension
1
Gastrointestinal Diseases
1
Fatigue
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bipolar Disorder
1
Arthritis, Psoriatic
1
Anemia
1
Interventions
Therapeutics
21
Psychiatric Rehabilitation
20
Surveys and Questionnaires
7
Early Intervention, Educational
6
Counseling
6
Yoga
5
Psychosocial Intervention
5
Cognitive Behavioral Therapy
5
Behavior Therapy
5
Mindfulness
4
Ketamine
4
Exercise
4
Escitalopram
4
Acupuncture Therapy
4
Saline Solution
3
Psilocybin
3
Mindfulness-Based Stress Reduction
3
Mindfulness-Based Cognitive Therapy
3
Methods
3
Exercise Therapy
3
Control Groups
3
Citalopram
3
Chemotherapy, Adjuvant
3
Sugars
2
Sertraline
2
Palliative Care
2
Observation
2
Niacin
2
Mental Status and Dementia Tests
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Depression
×
Infliximab
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts